Five-node biopsy of the axilla: An alternative to axillary dissection of levels I-II in operable breast cancer

European Journal of Surgical Oncology

Volumn 28, Issue 2, 2002, Pages 97-102

  Ahlgren, J ^a,b,c   Holmberg, L ^a   Bergh, J ^b   Liljegren, G ^c,d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^d CAMTÖ Centre for Assessment of Medical Technology in Örebro   (Sweden)

Author keywords

Axillary dissection; Breast cancer; Lymph node biopsy; Lymph node status

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 0036491168     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1228     Document Type: Article

References (35)

1. Postoperative lymph oedema after treatment of breast cancer
2. Shoulder movement following mastectomy
3. Assessment of morbidity from complete axillary dissection
4. Impact of axillary lymph node dissection on the therapy of breast cancer patients
5. Risk of lymph oedema following the treatment of breast cancer
6. Sequelae of axillary dissection v.s. axillary sampling with or without irradiation for breast cancer
7. Oedema of the arm as a function of the extent of axillary surgery in patients with stage I-III cancer if the breast treated with primary radiotherapy
8. Level I and II axillary dissection in the treatment of early stage breast cancer: Analysis of 259 consecutive patients
9. Conservation treatment of early breast cancer: Long term results and complication
10. Management of the axilla in conservative treated breast cancer: 592 Patients treated at the Institute Gustave-Roussy
11. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial
12. Is axillary lymph node dissection necessary in routine management of breast cancer?
13. The importance of surgery accurate axillary sampling for survival of breast cancer
14. Treatment of early breast cancer
15. The Edinburgh randomized trial of axillary sampling or clearance after mastectomy
16. Management of the axilla in operable breast cancer treated by breast conservation: A randomized clinical trial
17. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial
18. Axillary lymph node dissection for Tla breast carcinoma. Is it indicated?
19. Histological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years
20. Users' guide to the medical literature, part III. How to use an article about a diagnostic test. What are the results and will they help me in caring for my patients?
21. Polychemotherapy for early breast cancer: An overview of the randomised trials
22. Tamoxifen for early breast cancer: An overview of randomised trials
23. The 1998 St Gallen's consensus conference: An assessment
24. Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients
25. Axillary dissection of level I and II lymph nodes is important in breast cancer classification
26. Present and future projects of the International Breast Cancer Study Group
27. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
28. Improved axillary staging of breast cancer with sentinel lymphadenectomy
29. Mammary lymphoscintigraphy in breast cancer
30. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
31. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
32. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
33. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results from a large series
34. Sentinel node biopsy for breast cancer may have little to offer four-node-samplers: Results of a prospective comparison study
35. Editorial comment: Why remove four by chance when one will suffice?